Studies in double transgenic mice demonstrated that Ngb levels reduce amyloid-beta (Aβ) deposits, decrease level of Aβ (1-40) and Aβ (1-42), and improve behavioral performance, thereby abating the Alzheimer's disease phenotype [5, 27]. The gene discussed is NGB; the disease is early-onset autosomal dominant Alzheimer disease.